3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Thyroid Nodule
3
Thyroid Cancer, Papillary
3
Prostatic Neoplasms
3
Thyroid Neoplasms
2
Urinary Bladder, Neurogenic
1
Spinal Dysraphism
1
Prostatic Hyperplasia
1
Papillary Thyroid Microcarcinoma
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Hypospadias
1
Depression
1
Carcinoma
1
Bladder Exstrophy
1
Anxiety Disorders
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
6
Radiotherapy
2
Quality of Life
2
Phlebotomy
2
Interviews as Topic
2
Drug Therapy
2
zolbetuximab
1
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
iopromide
1
capecitabine-irinotecan combination
1
X-Rays
1
Tumor Burden
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Risedronic Acid
1
Registries
1
Raloxifene Hydrochloride
1
Radiofrequency Ablation
1
Radiation, Ionizing
1
Radiation
1
Positron-Emission Tomography
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Ipilimumab
1
Induction Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Adenocarcinoma
×
Transurethral Resection of Prostate
×
Clear all
NCT07237399
2026-05-13
TA-P-OLIM
University Hospital, Ghent
Withdrawn